Digital Look

Welcome to Digital Look++,
you are not logged in

Proteome Sciences (PRM)

Pharma and Biotech

2.01p

Trade now with Barclays Stockbrokers

Select chart: EPS | Dividend | Revenue

Period Ending	Period	Revenue (£m)	Pre-tax (£m)	EPS	Dividend
30-Jun-25	Interim	1.86	(2.07)	(0.73)p	n/a

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-20	4.75	0.24	0.10p	38.7	0.4	+100%	n/a	0.0%
31-Dec-21	5.12	0.12	0.02p	256.3	n/a	-80%	n/a	0.0%
31-Dec-22	7.78	1.25	0.45p	7.8	0.0	+2,150%	n/a	0.0%
31-Dec-23	5.03	(2.42)	(0.83)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-24	4.89	(3.25)	(1.15)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts data is not available for this company.

	5 Yr High	5 Yr Low	5 Yr Avg	Curr / Avg
Latest	38.70	n/a	58.86	0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

Find out about IFRS and how this affects the financial infomation for all UK companies.